RE104 is a psychedelic prodrug that was safe and well tolerated by healthy participants in a phase 1 clinical trial. RE104 produced an effective response at 33 mg which will be the effective dose used in the phase 2 trial investigating its efficacy in the treatment of PPD. The Latest A first-in-human, double-blind phase 1 clinical trial funded by Reunion Neuroscience
MORRISTOWN, N.J., April 03, 2024 Reunion Neuroscience Inc., a venture backed clinical-stage biopharmaceutical company committed to pushing the boundaries of neuroscience, today announced that.
Safe Supply Streaming Co Ltd : Safe Supply Streaming Co Ltd Announces Appointment of Ronan Levy as President finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Safe Supply Streaming Co. Ltd. , the first company investing in and incubating companies at the forefront of the third wave of drug policy reform, announced today that it has appointed Ronan Levy as.
Reunion Neuroscience Inc to Participate in October Investor Conferences streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.